SAGILITY NSE filing

Sagility Q1 FY27 Revenue Up 27.6% to ₹19,635 Million; Acquires CareSeed

The RealCase readHigh impact Positive

Sagility Limited reported Q1 FY27 revenue of ₹19,635 Million, a 27.6% YoY increase. The company acquired CareSeed for ~$5.1M CY25 revenue, adding 26 new clients and strengthening healthcare quality capabilities. Adjusted EBITDA grew 15.2% YoY to ₹4,716 Million, and Adjusted PAT rose 35.1% YoY to ₹2,697 Million.

Why it matters

The substantial revenue growth, strategic acquisition of a company with significant recurring revenue and new clients, and positive financial metrics indicate a high impact on the company's future prospects.

The market read

The company reported strong YoY revenue growth, significant acquisition of ACV, and successful strategic acquisition of CareSeed, all indicating positive business performance and expansion.

Sagility Limited announced its financial results for the first quarter of Fiscal Year 2027 (Q1 FY27), reporting a significant year-over-year (YoY) organic growth of 27.3% in Q1 FY27. This growth was primarily driven by expansion within existing clients and an increased contribution from new client wins in FY26.

The company secured $35.3 million in steady-state Annual Contract Value (ACV) during Q1 FY27, stemming from expansion opportunities and new Statements of Work (SOWs) across 18 existing clients and one new logo.

A key strategic move during the quarter was the acquisition of CareSeed, a U.S.-based healthcare analytics company. This acquisition is expected to strengthen Sagility's position in healthcare quality, particularly for Medicare Advantage plans, by adding differentiated analytics and HEDIS capabilities, and expanding platform depth and mid-market reach. The CareSeed acquisition also brought 26 new clients to Sagility.

Performance Highlights for Q1 FY27 include Revenue of ₹19,635 Million (US$207.8M), a 27.6% YoY growth. Adjusted EBITDA stood at ₹4,716 Million (US$49.9M), with a 15.2% YoY growth (14.9% in constant currency), and an Adjusted EBITDA margin of 24.0%. Adjusted Profit After Tax (PAT) was ₹2,697 Million (US$28.6M), showing a 35.1% YoY growth, with an Adjusted PAT margin of 13.7%.

Sagility also highlighted the impact of statutory minimum wage increases in Karnataka and Telangana, effective May 22, 2026, and June 1, 2026, respectively. The company reported a Forex loss of ₹283 Million in Q1 FY27, primarily driven by foreign exchange hedges.

In terms of recognitions, Sagility India was ranked 11th among India's 100 Best Companies to Work For 2026 by Great Place to Work® India and was recognized by ET Edge as a Best Organization for Women. It was also identified as a Major Contender in healthcare CXM and RCM Intelligent Operations PEAK Matrix® Assessments and a Leader in Avasant's Clinical and Care Management Business Process Transformation RadarView™.

The company's balance sheet as of June 30, 2026, shows Total Assets of ₹127,884 Million and Equity of ₹99,265 Million. The company expects to fully repay its debt in the current financial year.

Filing to action

What to do with a filing like this

SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under other company updates. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.

View original filing